ClinicalTrials.Veeva

Menu

Evaluation of EarlySense Home Care Tele-monitoring Device

S

Sheba Medical Center

Status

Unknown

Conditions

Cardiac Surgery
Myocardial Infarction

Treatments

Other: Home Monitoring

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02318004
SHEBA-14-0987-RK-CTIL

Details and patient eligibility

About

The aims of the present study are to evaluate the information obtained by the EarlySenese monitoring system and examine correlation of the obtained data and clinical events.

Full description

The EarlySense Home Care System developed by EarlySense, Ltd., is a contact-less tele-monitoring system. The system is intended for continuous monitoring of patients' respiration rate, heart rate and patient's motion.

The system, which monitors the patient while in bed, consists of a piezoelectric sensor that produces an electrical signal in response to physiological stimulation, and a microprocessor control unit that analyzes the recorded signal and identifies respiratory and heart rates and patient motion, while patient is in bed,. In addition, the system indicates patient's in or out of bed status. The system also provides alerts if either of the physiological parameters cross predefined threshold settings (e.g., high/ low heart rate or respiratory rate, or motion or time in bed).

The system saves patient's parameters and then flags the patients, as those to have changes in their vital signs and motion, or those that do not have noteworthy changes during recent hours of monitoring. Flagging of the patients are based on changes detected in patients' baseline vital signs (heart and respiratory rates and patterns) and well as recognition of changes in patients motion and in and out of bed status in comparison to set thresholds.

The aim of this study is to evaluate relevance of the information (vital sign trends, alerts and flags) as provided by the EarlySense Home Care Tele-monitoring system to medical staff in Sheba Medical Center's Heart Rehabilitation Institute (Shelev) in order proactively monitor patients at home. The correlation between the EarlySense system alerts and flags to patient deterioration and hospital readmission will be studied.

Enrollment

50 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients who resided in Shelev following a cardiac event (cardiac surgery, myocardial infarction, pacemaker implantation or other cardiac interventions )
  2. Age ≥ 21 years
  3. Any patient hosted in Shelev with geographically resident within 50 Km from Sheba Medical Center
  4. Patients agrees to sign the consent form and able to comply with study protocol.
  5. Sleeps on a mattress

Exclusion criteria

  1. Planned readmission within 30 days of discharge from hospital
  2. Discharge to hospice care.
  3. Patients with cognitive disabilities
  4. Patient's major treating hospital is not the Sheba Medical Center

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Home monitoring
Experimental group
Description:
Home monitoring via the EarlySense non-invasive nocturnal monitoring system. Movement, heart rate and respiratory rates will be monitored while subject is in his bed. The trends of monitored values will be daily reported to a central repository. No intervention will be attempted and care will be coordinated by the family physician and treating cardiologist as usual.
Treatment:
Other: Home Monitoring

Trial contacts and locations

1

Loading...

Central trial contact

Robert Klempfner, MD; Meirav Moreno, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems